Good point but personally I just ignore all of his posts. Imo Goldman is just being ridiculous going on the big biz bar show but he does sometimes give out info, this time changing expectations to the fall. Wonder what if anything they will say at asm and asco
Les job is to confuse the enemy... big pharma. Not keep retail informed. Consensus is now that in 2015 nwbo management knew they were pushing out approvoal to 2021 to prove overall survival and more important create closed manufacturing to do away with expensive clean rooms. They knew this yet held out the carrot of trial completion to retail for years to keep this company alive. And it worked! So now some are complaining that Les dampened expectations with his words on big biz show. But the reality is he created false hopes and expectations since 2016 to keep retail invested,and keep this company alive. Now when his message is not to count on immenent approvoal some are taking that as gospel. Think about it... we have been waiting since 2015 and the message was were on the cusp of breakthrough. Now the last year very little promotion and no cheap stock sold .
News 
Market Data 
Discover 
